Ge healthcare launches cardiovisio for atrial fibrillation, a digital, patient-centric clinical decision support tool to enable precision care

Chicago--(business wire)--today, ge healthcare (nasdaq: gehc) announces the launch of cardiovisio for atrial fibrillation (afib), a digital tool designed to assist clinicians in visualizing longitudinal data relevant for disease progression from multiple data sources, and driving evidence based clinical decision support directed by up-to-date afib guidelines. the new technology will be showcased at the european society of cardiology (esc) congress 2023, in amsterdam, netherlands, august 25-28.
GEHC Ratings Summary
GEHC Quant Ranking